Biosimilars and Bone Health - Episode 1

Optimizing Biosimilar Treatment Strategies in Bone Health

Colin C. Edgerton, MD, discusses key considerations for utilizing biosimilars in the bone health treatment landscape.

Now Viewing
EP. 1: Optimizing Biosimilar Treatment Strategies in Bone Health
EP. 2: Managing Treatment Strategies for Osteoporosis Amid Evolving Biologic and Biosimilar Landscape

*Content was developed independently by The Center for Biosimilars® and supported by Sandoz.

Related Content:

Video SeriesInterviewsInsightsClinical
Empowering Vulnerable Populations: The Path to Equitable Biologic Therapy Access
The Top 5 Biosimilar Articles for the Week of December 16
Strategies for Improving Biosimilar Access and Utilization